Filing Flows

Filing Flows › Voyager Therapeutics (VYGR) › Who owns the stock

Who owns Voyager Therapeutics (VYGR) stock

129 funds reported Voyager Therapeutics (VYGR) shares in their latest 13F filings, worth $135M in all. The largest holder is BlackRock ($18.1M). Last quarter 71 funds added to their stakes and 43 cut them.

Largest holders of VYGR (13F)Largest holders of VYGR (13F)BlackRock$18.1MMillennium Management LLC$15.6MVanguard Group$12.8MArmistice Capital, LLC$12.0MVestal Point Capital, LP$9.2MVanguard Capital Management LLC$8.2MGeode Capital Management, LLC$4.7MOpaleye Management$4.1MState Street$3.8MTwo Sigma Investments, LP$3.3M

Largest holders (13F)

FundSharesValueChangeQuarter
BlackRock5,172,063$18.1Mdecrease2026-06-30
Millennium Management LLC4,442,951$15.6Mincrease2026-06-30
Vanguard Group3,266,484$12.8Mincrease2025-12-31
Armistice Capital, LLC3,436,000$12.0Mdecrease2026-06-30
Vestal Point Capital, LP2,625,000$9.2Mdecrease2026-06-30
Vanguard Capital Management LLC2,345,674$8.2Mincrease2026-06-30
Geode Capital Management, LLC1,330,492$4.7Mincrease2026-06-30
Opaleye Management1,185,000$4.1Mincrease2026-06-30
State Street1,076,422$3.8Mincrease2026-06-30
Two Sigma Investments, LP948,517$3.3Mincrease2026-06-30
Dimensional Fund Advisors LP838,184$2.9Mdecrease2026-06-30
Vanguard Portfolio Management LLC810,091$2.8Mincrease2026-06-30
Citadel Advisors LLC784,067$2.7Mincrease2026-06-30
Morgan Stanley697,334$2.4Mincrease2026-06-30
Erste Asset Management GmbH638,900$2.3Mdecrease2026-06-30

Voyager Therapeutics' latest quarter

Voyager Therapeutics, Q3 2026: revenue $4.0M (-70% year over year), operating margin -658.2%, net loss $24.7M, operating cash flow −$19.7M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most VYGR stock?

By the latest 13F filings: BlackRock ($18.1M); Millennium Management LLC ($15.6M); Vanguard Group ($12.8M); Armistice Capital, LLC ($12.0M); Vestal Point Capital, LP ($9.2M).

What is the short interest in VYGR?

3,638,416 shares were sold short at the 2026-10-15 settlement, -8.43% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.